Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz

Piketty, C Race, E Castiel, P Belec, L Peytavin, G Si-Mohamed, A Gonzalez-Canali, G Weiss, L Clavel, F Kazatchkine, MD

C. Piketty et al., Phenotypic resistance to protease inhibitors in patients who fail on highly active antitetroviral therapy predicts the outcome at 48 weeks of a five-drug combination including ritonavir, saquinavir and efavirenz, AIDS, 14(5), 2000, pp. 626-628

7

Immunology

AIDS

02699370 → ACNP

14

5

2000

626 - 628

ISI

0269-9370(20000331)14:5<626:PRTPII>2.0.ZU;2-G